Skip to main content

Perimeter Medical Imaging AI Stock Forecast, Price & News

+0.01 (+0.37 %)
(As of 05/13/2021 02:50 PM ET)
Today's Range
50-Day Range N/A
52-Week Range
Volume6,240 shs
Average Volume16,264 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PYNKF News and Ratings via Email

Sign-up to receive the latest news and ratings for Perimeter Medical Imaging AI and its competitors with MarketBeat's FREE daily newsletter.

About Perimeter Medical Imaging AI

Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Industry Medical Devices
Phone647 360 0302
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

1.70 out of 5 stars

Medical Sector

299th out of 2,039 stocks

Medical Devices Industry

6th out of 37 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Perimeter Medical Imaging AI (OTCMKTS:PYNKF) Frequently Asked Questions

Is Perimeter Medical Imaging AI a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perimeter Medical Imaging AI in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Perimeter Medical Imaging AI stock.
View analyst ratings for Perimeter Medical Imaging AI
or view top-rated stocks.

What stocks does MarketBeat like better than Perimeter Medical Imaging AI?

Wall Street analysts have given Perimeter Medical Imaging AI a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Perimeter Medical Imaging AI wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Perimeter Medical Imaging AI?

Perimeter Medical Imaging AI saw a decrease in short interest in April. As of April 15th, there was short interest totaling 9,200 shares, a decrease of 52.3% from the March 31st total of 19,300 shares. Based on an average trading volume of 35,300 shares, the days-to-cover ratio is currently 0.3 days.
View Perimeter Medical Imaging AI's Short Interest

What price target have analysts set for PYNKF?

1 equities research analysts have issued 1-year target prices for Perimeter Medical Imaging AI's stock. Their forecasts range from $6.50 to $6.50. On average, they anticipate Perimeter Medical Imaging AI's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 140.7% from the stock's current price.
View analysts' price targets for Perimeter Medical Imaging AI
or view top-rated stocks among Wall Street analysts.

Who are Perimeter Medical Imaging AI's key executives?

Perimeter Medical Imaging AI's management team includes the following people:
  • Mr. Jeremy Sobotta, CEO & Pres
  • Ms. Elizabeth Munro, Founder & Pres of Canadian Operations
  • Mr. Andrew Berkeley, Co-Founder & Head of Bus. Devel.
  • Mr. David Rempel, Founder and Head of R&D
  • Mr. Merle Thomas Boon, Chief Operating Officer
  • Mr. Vladimir Pekar, Head of AI Algorithm Devel.
  • Ms. Rochelle Keen, Head of Clinical Research Programs
  • Mr. Carl Gazdzinski, Head of Engineering & Manufacturing
  • Mr. Steve Sapot, Chief Commercial Officer

Who are some of Perimeter Medical Imaging AI's key competitors?

What is Perimeter Medical Imaging AI's stock symbol?

Perimeter Medical Imaging AI trades on the OTCMKTS under the ticker symbol "PYNKF."

How do I buy shares of Perimeter Medical Imaging AI?

Shares of PYNKF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perimeter Medical Imaging AI's stock price today?

One share of PYNKF stock can currently be purchased for approximately $2.70.

What is Perimeter Medical Imaging AI's official website?

The official website for Perimeter Medical Imaging AI is

How can I contact Perimeter Medical Imaging AI?

The company can be reached via phone at 647 360 0302.

This page was last updated on 5/14/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.